Mediation of Epstein-Barr virus EBNA-LP transcriptional coactivation by Sp100

被引:72
作者
Ling, PD
Peng, RS
Nakajima, A
Yu, JH
Tan, J
Moses, SM
Yang, WH
Zhao, B
Kieff, E
Bloch, KD
Bloch, DB
机构
[1] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA
[2] Harvard Univ, Sch Med, Dept Med, Boston, MA USA
[3] Massachusetts Gen Hosp, Gen Med Serv, Ctr Immunol & Inflammatory Dis, Boston, MA 02114 USA
[4] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA
[5] Brigham & Womens Hosp, Dept Microbiol & Mol Genet, Channing Lab, Boston, MA USA
[6] Massachusetts Gen Hosp, Gen Med Serv, Cardiovasc Res Ctr, Boston, MA 02114 USA
关键词
Epstein-Barr virus; gene regulation; latency; nuclear bodies; Sp100;
D O I
10.1038/sj.emboj.7600820
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Epstein-Barr virus (EBV) EBNA-LP protein is important for EBV-mediated B-cell immortalization and is a potent gene-specific coactivator of the viral transcriptional activator, EBNA2. The mechanism(s) by which EBNA-LP functions as a coactivator remains an important question in the biology of EBV-induced B-cell immortalization. In this study, we found that EBNA-LP interacts with the promyelocytic leukemia nuclear body (PML NB)-associated protein Sp100 and displaces Sp100 and heterochromatin protein 1 alpha (HP1 alpha) from PML NBs. Interaction between EBNA-LP and Sp100 was mediated through conserved region 3 in EBNA-LP and the PML NB targeting domain in Sp100. Overexpression of Sp100 lacking the N-terminal PML NB targeting domain, but not a mutant form of Sp100 lacking the HP1a interaction domain, was sufficient to coactivate EBNA2 in a gene-specific manner independent of EBNA-LP. These findings suggest that Sp100 is a major mediator of EBNA-LP coactivation. These studies indicate that modulation of PML NB-associated proteins may be important for establishment of latent viral infections, and also identify a convenient model system to investigate the functions of Sp100.
引用
收藏
页码:3565 / 3575
页数:11
相关论文
共 68 条
  • [61] The Epstein-Barr virus-encoded nuclear antigen EBNA-5 accumulates in PML-containing bodies
    Szekely, L
    Pokrovskaja, K
    Jiang, WQ
    deThe, H
    Ringertz, N
    Klein, G
    [J]. JOURNAL OF VIROLOGY, 1996, 70 (04) : 2562 - 2568
  • [62] SZEKELY L, 1995, ONCOGENE, V10, P1869
  • [63] SZOSTECKI C, 1987, CLIN EXP IMMUNOL, V68, P108
  • [64] SZOSTECKI C, 1990, J IMMUNOL, V145, P4338
  • [65] NUCLEAR DOT ANTIGENS MAY SPECIFY TRANSCRIPTIONAL DOMAINS IN THE NUCLEUS
    XIE, KW
    LAMBIE, EJ
    SNYDER, M
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (10) : 6170 - 6179
  • [66] Identification of major phosphorylation sites of Epstein-Barr virus nuclear antigen leader protein (EBNA-LP): Ability of EBNA-LP to induce latent membrane protein 1 cooperatively with EBNA-2 is regulated by phosphorylation
    Yokoyama, A
    Tanaka, M
    Matsuda, G
    Kato, K
    Kanamori, M
    Kawasaki, H
    Hirano, H
    Kitabayashi, I
    Ohki, M
    Hirai, K
    Kawaguchi, Y
    [J]. JOURNAL OF VIROLOGY, 2001, 75 (11) : 5119 - 5128
  • [67] B-cell lines immortalized with an Epstein-Barr virus mutant lacking the Cp EBNA2 enhancer are biased toward utilization of the oriP-proximal EBNA gene promoter Wp1
    Yoo, LI
    Mooney, M
    Puglielli, MT
    Speck, SH
    [J]. JOURNAL OF VIROLOGY, 1997, 71 (12) : 9134 - 9142
  • [68] SP100 expression modulates ETS1 transcriptional activity and inhibits cell invasion
    Yordy, JS
    Li, RZ
    Sementchenko, VI
    Pei, HP
    Muise-Helmericks, RC
    Watson, DK
    [J]. ONCOGENE, 2004, 23 (39) : 6654 - 6665